A Rejuvenated Liver Cuts Alzheimer's Markers by Half in Rats
USC researchers found restoring liver cell function halved circulating amyloid-linked proteins and lowered cholesterol, pointing toward systemic clearance rather than isolated brain interventions.
For decades, neurodegenerative research focused almost entirely on the skull. If amyloid-beta and tau proteins accumulated in neural tissue, the assumption was that the brain had to clear them on its own. A study from researchers at the University of Southern California challenges that assumption by examining the body's primary filtration engine: the liver.
In experiments using aging rats, investigators administered an experimental compound designed to restore aging hepatocytes. The intervention revived a dormant cellular signaling mechanism that older liver tissue normally loses. Once this clearance channel was restored, circulating levels of an Alzheimer's-linked protein dropped by 50 percent, while LDL cholesterol measurements fell back to levels typical of young animals.
The liver filters approximately 1.4 liters of blood every minute, removing metabolites, misfolded proteins, and environmental toxins before they reach systemic circulation. When hepatic cells enter senescence, that clearance capacity drops. If peripheral clearance stalls, neurotoxic molecules have longer residence times in the bloodstream, increasing the burden across the blood-brain barrier.
Rodent models do not automatically translate to human clinical outcomes, and this compound is still far from regulatory review. For now, pay attention to your routine liver panels: AST, ALT, and lipid fractions tell a story about systemic filtration that matters well above your neck.
The longer view
One headline rarely tells the story. See how today’s news fits the bigger shifts on AI Trends, or learn to read your own data on How it works.